Search results
Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Zacks via Yahoo Finance· 2 days agoMyriad Genetics, Inc. MYGN recently announced a collaboration with GSK plc GSK to advance in the...
Myriad Genetics' (MYGN) New Platform to Advance Cancer Care
Zacks via Yahoo Finance· 6 months agoMyriad Genetics, Inc. MYGN recently launched the Myriad Collaborative Research Registry (“MCRR”) — a...
Myriad Genetics (MYGN) Gets Permit to Expand Tumor Testing
Zacks via Yahoo Finance· 1 year agoMyriad Genetics (MYGN) and Intermountain Precision Genomics receive the New York State Clinical...
Myriad Genetics (MYGN) Expands Pharma Services With New Pact
Zacks via Yahoo Finance· 7 months agoMyriad Genetics (MYGN) will market the Personalis ImmunoID NeXT ultra-comprehensive biomarker...
Myriad Genetics (MYGN) Teams Up to Assess Breast Cancer Risk
Zacks via Yahoo Finance· 10 months agoMyriad Genetics, Inc. MYGN recently announced the launch of a new breast cancer risk assessment...
Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay
Zacks via Yahoo Finance· 3 months agoMyriad Genetics, Inc. MYGN recently announced the issuance of a patent by the United States Patent...
Myriad Genetics (MYGN) Unveils GeneSight Test Enhancement
Zacks via Yahoo Finance· 10 months agoMyriad Genetics, Inc. MYGN recently announced improvements to the GeneSight Psychotropic test, a...
Genetic Testing Pioneer Myriad Genetics' Evolution Draws Analyst Attention Amid New Product(s)...
Benzinga via Yahoo Finance· 6 months agoPiper Sandler initiated coverage on Myriad Genetics Inc (NASDAQ: MYGN), noting that many investors...
Why Shares of Myriad Genetics Dropped 24% This Week
Motley Fool· 2 years agoWhat happened Shares of Myriad Genetics (NASDAQ: MYGN), a genetic-testing and precision-medicine biotech company, were down more than 24% this week as of...
4 big analyst picks: Battered regional banks becoming buys
Investing.com via Yahoo Finance· 1 year agoInvesting.com -- Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Outperform initiation at Zions Bancorp and upgrades at KeyCorp, Greenhill, and Myriad Genetics.